市場調査レポート
商品コード
1115332

非ステロイド性抗炎症薬の世界市場規模、シェア、産業動向分析レポート:投与経路別、流通チャネル別、適応症別、地域別展望と予測、2022年~2028年

Global Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028

出版日: | 発行: KBV Research | ページ情報: 英文 225 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
非ステロイド性抗炎症薬の世界市場規模、シェア、産業動向分析レポート:投与経路別、流通チャネル別、適応症別、地域別展望と予測、2022年~2028年
出版日: 2022年07月29日
発行: KBV Research
ページ情報: 英文 225 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

非ステロイド性抗炎症薬の世界市場規模は、2028年までに255億米ドルに達し、予測期間中にCAGR5.7%の市場成長率で上昇すると予測されています。

予測期間中、慢性疼痛の有病率は増加すると予想され、NSAID市場の成長を促進しています。例えば、CDCは、米国では2019年に成人の約20,4%が慢性疼痛を経験したと推定しています。慢性疼痛の有病率における年齢による増加は、65歳以上で最も顕著に見られます。ヒスパニック系、非ヒスパニック系アジア人、非ヒスパニック系黒人と比較して、非ヒスパニック系白人の慢性疼痛の有病率が最も高かったです。非ヒスパニック系白人の成人の約23.6%が慢性的な不快感に悩まされています。したがって、COX-2選択的および非選択的NSAIDsの両方が慢性疼痛の管理に頻繁に採用されていることを考えると、慢性疼痛の有病率の増加が成長を促進すると予想されます。

COVID-19の影響分析

感染症COVID-19は、12月下旬に中国湖北省の武漢市で初めて表面化しました。SARS-CoV-2という急性呼吸器症候群を引き起こすウイルスは、非常に感染力が強く、人から人へと広がっていく。2019年12月の発生以来、ウイルスは213カ国に広がり、世界保健機関はパンデミック(世界的流行病)に分類しています。COVID-19の発生に対して、世界各国の政府や製薬・バイオテクノロジー企業は、医療サプライチェーンの管理から予防接種の作成支援に至るまで、共同で取り組んでいます。その結果、COVID-19ワクチン接種とその治療薬に対する需要が、製薬およびバイオテクノロジー分野を前進させると予測されています。

市場成長要因

慢性疼痛の発生率の増加

薬物療法や治療なしに12週間以上続く痛みは、慢性痛または持続性痛と呼ばれます。怪我や手術による痛みから回復し、元通りになる人もいます。しかし、事故や手術の前歴がなくても、痛みが長く続いたり、突然痛みが現れたりすることがあります。非ステロイド性抗炎症薬の市場拡大の主な要因の1つは、痛みや炎症を引き起こす疾患の有病率が上昇していることです。これらの薬剤は、急性および慢性の痛みの治療に頻繁に使用されています。イブプロフェン&ジクロフェナクは、頻繁に痛みを治療するために推奨されている2つの薬です。

オピオイドよりNSAIDを好む人が増えています。

軽度から重度の疼痛管理に最もよく使用されるのは、非ステロイド性抗炎症薬とオピオイドです。しかし、オピオイドの使用は、深刻な有害事象と関連しています。数千年前の文明の夜明け以来、オピオイドは痛みを和らげるために使用されてきました。オピオイド鎮痛薬は、鈍い痛み、局所的でない痛み、典型的には腹痛の治療に頻繁に使用されます。頻繁に服用すると薬物耐性と依存性が生じ、オピオイド鎮痛剤を突然止めると禁断症状を引き起こす可能性があります。オピオイドを含まない非ステロイド性抗炎症薬(NSAIDs)は、疼痛管理のために最も頻繁に処方される鎮痛剤です。これらの医薬品は、大量に服用することで、解熱、鎮痛、抗炎症作用も発揮します。

市場抑制要因

Nsaidsの副作用による消費量の制限

アレルギー反応、胃痛、胃潰瘍、めまいなど、NSAIDの使用による副作用が市場の成長を抑制すると予想されます。NSAIDは、その入手のしやすさと抗炎症作用から、最も多く処方される医薬品の一つです。しかし、NSAIDに関連する消化器系の問題は世界的に著しく増加しており、ヘルスケアシステムに負担をかける可能性があります。緊急入院の最も多い理由は、NSAIDsに関連する消化管出血です。さらに、その副作用は、米国で最も典型的な薬物副作用となっています。

疾患別適応症の展望

非ステロイド性抗炎症薬市場は、適応症に基づき、関節炎、偏頭痛、眼科疾患、その他に区分されます。2021年の非ステロイド性抗炎症薬市場では、関節炎セグメントが最も高い収益シェアを獲得しました。関節炎および変形性関節症の全体的な発生率、世界の高齢者人口の増加、NSAIDsの強い処方率、局所関節炎治療薬の人気の上昇などが、このセグメントの成長の要因となっています。

投与経路の展望

非ステロイド性抗炎症薬市場は、投与経路別に、経口剤、局所剤、その他に分類されます。2021年の非ステロイド性抗炎症薬市場では、経口セグメントが最大の収益シェアを獲得しています。これは、痛み、頭痛、発熱、片頭痛の治療に利用できる経口NSAIDsが豊富なことと、OTC NSAIDの売上が増加しているためです。頭痛や偏頭痛を治療するために、ジョンソン・エンド・ジョンソンコンシューマーインクは、NSAID薬のモトリン(イブプロフェン)を提供しており、タブレット、液体ゲル、カプセル、溶液などの投与形態で提供されています。

流通経路の展望

非ステロイド性抗炎症薬市場は、流通チャネル別に病院薬局、小売薬局、オンライン薬局に分類されます。病院薬局セグメントは、2021年の非ステロイド性抗炎症薬市場で大きな収益シェアを獲得しました。それは、非ステロイド性抗炎症薬が入院患者の痛みを治療するために広く使用されているためです。それとともに、世界各国の病院数の増加が、予測期間中の同分野の成長をエスカレートさせるでしょう。

地域別の展望

地域別に見ると、非ステロイド性抗炎症薬市場は、北米、欧州、アジア太平洋およびLAMEAで分析されています。北米は、2021年に最大の収益シェアを獲得し、非ステロイド性抗炎症薬市場の主要地域として浮上しました。市場の成長に影響を与える重要な変数には、相当数のメーカーの存在や、業界参加者による戦略的行動などがあります。また、予測期間中に関節炎や慢性疼痛の有病率が上昇し、成長が加速することが予測されています。

目次

第1章 市場の範囲と調査手法

  • 市場の定義.
  • 目的.
  • 市場規模.
  • セグメンテーション.
    • 非ステロイド性抗炎症薬の世界市場:投与経路別
    • 非ステロイド性抗炎症薬の世界市場:流通経路別
    • 非ステロイド性抗炎症薬の世界市場:疾患適応症別
    • 非ステロイド性抗炎症薬の世界市場:地域別
  • 調査手法

第2章 市場概要

  • イントロダクション.
    • 概要説明
      • 市場の構成とシナリオ.
  • 市場に影響を与える主な要因.
    • 市場促進要因.
    • 市場抑制要因.

第3章 非ステロイド性抗炎症薬市場で展開されている最新戦略

第4章 非ステロイド性抗炎症薬の世界市場:投与経路別

  • 経口剤の世界市場:地域別
  • 局所薬の世界市場:地域別
  • その他の地域別世界市場

第5章 非ステロイド性抗炎症薬の世界市場:流通チャネル別

  • 小売薬局の世界市場:地域別
  • 病院内薬局の世界市場:地域別
  • 世界のオンライン薬局市場:地域別

第6章 非ステロイド性抗炎症薬の世界市場:疾患別適応症

  • 関節炎の世界市場:地域別
  • 片頭痛の世界市場:地域別
  • 眼科疾患の世界市場:地域別
  • その他の地域別世界市場

第7章 非ステロイド性抗炎症薬の世界市場:地域別

  • 北米.
    • 北米の非ステロイド性抗炎症薬の国別市場
      • 米国
      • カナダ
      • メキシコ
      • 北米以外の地域
  • 欧州
    • 欧州の非ステロイド性抗炎症薬国別市場
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域の非ステロイド性抗炎症薬国別市場
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • LAMEA
    • LAMEAの非ステロイド性抗炎症薬市場:国別
      • ブラジル
      • アルゼンチン
      • UAE
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • LAMEAの他の地域

第8章 企業プロファイル

  • Dr. Reddy's Laboratories Ltd.
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly And Company
  • Sanofi S.A.
  • AstraZeneca PLC
  • Viatris, Inc.
  • Merck & Co., Inc.
図表

LIST OF TABLES

  • TABLE 1 Global Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 2 Global Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 3 Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 4 Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 5 Global Oral Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Oral Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Topical Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Topical Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 12 Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 13 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 20 Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 21 Global Arthritis Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Arthritis Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Migraine Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Migraine Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Ophthalmic Diseases Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Ophthalmic Diseases Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Non-steroidal Anti-inflammatory Drugs Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Non-steroidal Anti-inflammatory Drugs Market by Region, 2022 - 2028, USD Million
  • TABLE 31 North America Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 32 North America Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 33 North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 34 North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 35 North America Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 42 North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 43 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 50 North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 51 North America Arthritis Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Arthritis Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Migraine Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Migraine Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 60 North America Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 61 US Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 62 US Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 63 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 64 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 65 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 66 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 67 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 68 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 69 Canada Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 70 Canada Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 71 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 72 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 73 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 74 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 75 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 76 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 77 Mexico Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 78 Mexico Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 79 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 80 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 81 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 82 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 83 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 84 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 89 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 90 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 91 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 92 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 93 Europe Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 94 Europe Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 95 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 96 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 97 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 100 Europe Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 101 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 104 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 105 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 112 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 113 Europe Arthritis Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Arthritis Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Migraine Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Migraine Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Europe Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 120 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 121 Europe Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Germany Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 124 Germany Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 125 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 126 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 127 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 128 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 129 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 130 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 131 UK Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 132 UK Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 133 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 134 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 135 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 136 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 137 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 138 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 139 France Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 140 France Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 141 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 142 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 143 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 144 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 145 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 146 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 147 Russia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 148 Russia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 149 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 150 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 151 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 152 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 153 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 154 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 155 Spain Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 156 Spain Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 157 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 158 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 159 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 162 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 163 Italy Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 164 Italy Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 165 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 166 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 167 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 168 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 169 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 170 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 173 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 174 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 175 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 176 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 177 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 178 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Arthritis Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Arthritis Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Migraine Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Migraine Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 209 China Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 210 China Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 211 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 212 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 213 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 214 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 215 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 216 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 217 Japan Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 218 Japan Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 219 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 220 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 221 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 222 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 223 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 224 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 225 India Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 226 India Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 227 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 228 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 229 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 230 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 231 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 232 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 233 South Korea Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 234 South Korea Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 235 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 236 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 237 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 238 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 239 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 240 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 241 Singapore Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 242 Singapore Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 243 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 244 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 245 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 246 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 247 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 248 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 249 Malaysia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 250 Malaysia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 251 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 252 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 253 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 254 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 255 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 256 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 257 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 258 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 259 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 260 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 261 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 262 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 263 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 264 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 275 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 276 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 285 LAMEA Arthritis Market by Country, 2018 - 2021, USD Million
  • TABLE 286 LAMEA Arthritis Market by Country, 2022 - 2028, USD Million
  • TABLE 287 LAMEA Migraine Market by Country, 2018 - 2021, USD Million
  • TABLE 288 LAMEA Migraine Market by Country, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 293 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 294 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 295 Brazil Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 296 Brazil Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 297 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 298 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 299 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 300 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 301 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 302 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 303 Argentina Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 304 Argentina Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 305 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 306 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 307 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 308 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 309 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 310 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 311 UAE Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 312 UAE Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 313 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 314 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 315 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 316 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 317 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 318 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 319 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 320 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 321 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 322 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 323 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 324 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 325 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 326 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 327 South Africa Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 328 South Africa Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 329 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 330 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 331 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 332 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 333 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 334 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 335 Nigeria Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 336 Nigeria Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 337 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 338 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 339 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 340 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 341 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 342 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 343 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
  • TABLE 344 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
  • TABLE 345 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 346 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 347 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 348 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 349 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
  • TABLE 350 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
  • TABLE 351 key information - Dr. Reddy's Laboratories Ltd.
  • TABLE 352 Key Information - Pfizer, Inc.
  • TABLE 353 Key Information - GlaxoSmithKline PLC
  • TABLE 354 Key Information - Bayer AG
  • TABLE 355 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 356 Key Information - Eli Lilly And Company
  • TABLE 357 Key Information - Sanofi S.A.
  • TABLE 358 KEY INFORMATION - ASTRAZENECA PLC
  • TABLE 359 key information - Viatris, Inc.
  • TABLE 360 KEY INFORMATION - MERCK & CO., INC.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Non-steroidal Anti-inflammatory Drugs Market Share by Route of Administration, 2021
  • FIG 3 Global Non-steroidal Anti-inflammatory Drugs Market Share by Route of Administration, 2028
  • FIG 4 Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2028, USD Million
  • FIG 5 Global Non-steroidal Anti-inflammatory Drugs Market Share by Distribution Channel, 2021
  • FIG 6 Global Non-steroidal Anti-inflammatory Drugs Market Share by Distribution Channel, 2028
  • FIG 7 Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 8 Global Non-steroidal Anti-inflammatory Drugs Market Share by Disease Indication, 2021
  • FIG 9 Global Non-steroidal Anti-inflammatory Drugs Market Share by Disease Indication, 2028
  • FIG 10 Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2028, USD Million
  • FIG 11 Global Non-steroidal Anti-inflammatory Drugs Market Share by Region, 2021
  • FIG 12 Global Non-steroidal Anti-inflammatory Drugs Market Share by Region, 2028
  • FIG 13 Global Non-steroidal Anti-inflammatory Drugs Market by Region, 2018 - 2028, USD Million
  • FIG 14 Recent strategies and developments: Dr. Reddy's Laboratories Ltd.
目次

The Global Non-Steroidal Anti-inflammatory Drugs Market size is expected to reach $25.5 billion by 2028, rising at a market growth of 5.7% CAGR during the forecast period.

Non-steroidal anti-inflammatory medications (NSAIDs) are used to alleviate pain, lower fevers, and improve blood circulation. Furthermore, the inflammation is decreased when high dosages of non-steroidal anti-inflammatory medicines (NSAIDs) are given. Non-steroidal medications have sedative and anti-inflammatory effects. Inflammation is caused by the COX-1 and COX-2 enzymes that are inhibited by non-steroidal anti-inflammatory medications (NSAIDs). Aspirin, naproxen, ibuprofen, and paracetamol are examples of typical non-steroidal anti-inflammatory medications.

The market for non-steroidal anti-inflammatory medications (NSAIDs) is expanding as a result of a number of causes, including the growing incidence of chronic pain worldwide and an ageing population. The expanding use of NSAIDs for headache, toothache, migraine, and menstrual pain, as well as growing preference for OTC NSAIDs, are also anticipated to contribute to the growth over the forecast period. Additionally, the accessibility of a wide range of NSAID products as well as an increase in product approvals and launches are projected to fuel growth over the forecast period.

During the projected period, the prevalence of chronic pain is anticipated to increase, driving NSAID market growth. For instance, the CDC estimates that in the United States, about 20,4% of adults experienced chronic pain in 2019. Age-related increases in the prevalence of chronic pain were most pronounced in persons 65 years of age and older. Compared to Hispanic, non-Hispanic Asian, and non-Hispanic black individuals, non-Hispanic whites had the highest prevalence of chronic pain. About 23.6 percent of non-Hispanic white adults suffer from chronic discomfort. Therefore, given that both COX-2 selective and non-selective NSAIDs are frequently employed in the management of chronic pain, the increasing prevalence of chronic pain is anticipated to promote growth.

COVID-19 Impact Analysis

The infectious disease COVID-19 first surfaced in late December in the Chinese city of Wuhan's Hubei province. SARS-CoV-2, the virus that causes the acute respiratory syndrome is extremely contagious and spreads from person to person. The virus has spread to 213 nations since its outbreak in December 2019, prompting the World Health Organization to classify it as a pandemic. Governments and pharmaceutical and biotech businesses from all around the world are collaborating to combat the COVID-19 outbreak, from managing the medical supply chain to assisting in the creation of vaccinations. As a result, the demand for the COVID-19 vaccination and its treatment medications is predicted to propel the pharmaceutical and biotechnology sectors forward.

Market Growth Factors

Growing Incidence Of Chronic Pain

Pain that persists for more than 12 weeks without medication or treatment is referred to as chronic or persistent pain. Several people recover from pain due to injuries or operation and return to normalcy. However, there are situations when the pain lasts longer or appears suddenly without any prior history of an accident or surgery. One of the key factors propelling the market expansion for non-steroidal anti-inflammatory medications is the rising prevalence of disorders that cause pain and inflammation. These medications are being used more frequently to treat both acute & chronic pain. Ibuprofen & diclofenac are two medications that are frequently recommended to treat pain.

Increasing Preference Of People For Nsaids Over Opioids

The most often recommended medications for the management of mild to severe pain are NSAIDs and opioids. Opioid use, however, is linked to serious adverse outcomes. Since the dawn of civilization thousands of years ago, opioids have been used to relieve pain. Opioid analgesics are frequently used to treat dull, ill-localized pain, typically abdominal pain. Frequent doses may result in drug tolerance and dependency, and abruptly stopping an opioid painkiller may trigger a withdrawal crisis. Non-opioid, non-steroidal anti-inflammatory medicines (NSAIDs), which do not include opioids, are the most often prescribed analgesics for the management of pain. At larger doses, these medications also have antipyretic, analgesics, and anti-inflammatory properties.

Market Restraining Factors

Adverse Effects Of Nsaids Would Restrict Its Consumption

The market growth is anticipated to be constrained by adverse reactions to NSAID use, including allergic reactions, stomach pain, stomach ulcers, and dizziness. These pharmaceuticals are one of the most often prescribed medicines due to their widespread accessibility and anti-inflammatory effects. However, NSAID-related gastrointestinal issues are on the rise significantly globally, which could put a strain on the healthcare system. The most frequent reason for the most of emergency hospital admissions is GI bleeding related to NSAIDs. Additionally, its side effect is the most typical drug side in the United States.

Disease Indication Outlook

Based on disease indication, the Non-steroidal Anti-inflammatory Drugs Market is segmented into Arthritis, Migraine, Ophthalmic Diseases and Others. The arthritis segment acquired the highest revenue share in the Non-steroidal Anti-inflammatory Drugs Market in 2021. The overall incidence of arthritis & osteoarthritis, the growing senior population worldwide, the strong prescription rate for NSAIDs, and the rise in popularity of topical arthritis treatments are all contributing factors to the segment's growth.

Route of Administration Outlook

By Route of Administration, the Non-steroidal Anti-inflammatory Drugs Market is classified into Oral, Topical and Others. The oral segment garnered the maximum revenue share in the Non-steroidal Anti-inflammatory Drugs Market in 2021. It is due to the abundance of oral NSAIDs available for treating pain, headaches, fever, and migraines as well as the rise in OTC NSAID sales. To treat headaches and migraines, Johnson & Johnson Consumer Inc. provides their NSAID medication Motrin (ibuprofen), which is offered in dose forms such a tablet, liquid gel, capsule, and solution.

Distribution Channel Outlook

On the basis of distribution channel, the Non-steroidal Anti-inflammatory Drugs Market is divided into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. The hospital pharmacy segment acquired a significant revenue share in the Non-steroidal Anti-inflammatory Drugs Market in 2021. It is because non-steroidal anti-inflammatory medications are widely used to treat pain in hospitalized patients. Along with that, the rise in the number of hospitals across various nations of the world would escalate the growth of the segment over the forecast period.

Regional Outlook

Region-wise, the Non-steroidal Anti-inflammatory Drugs Market is analyzed across North America, Europe, Asia Pacific and LAMEA. North America emerged as the leading region in the Non-steroidal Anti-inflammatory Drugs Market with the maximum revenue share in 2021. Some of the key variables influencing the market's growth include the existence of a sizable number of manufacturers and the strategic actions made by industry participants. In addition, it is predicted that the prevalence of arthritis and chronic pain will rise during the forecast period, accelerating growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy's Laboratories Ltd., Pfizer, Inc., GlaxoSmithKline PLC, Bayer AG, Teva Pharmaceuticals Industries Ltd., Eli Lilly And Company, Sanofi S.A., AstraZeneca PLC, Viatris, Inc., and Merck & Co., Inc.

Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market

Partnerships, Collaborations and Agreements:

May-2022: Dr. Reddy's Laboratories formed a partnership with South Korea-based HK inno.N Corporation. Through this partnership, Tegoprazan would offer a new option for the treatment of gastric acid-related as well as mobility-impaired diseases like Erosive/Non-erosive Gastroesophageal Reflux Disease (GERD / NERD), Nonsteroidal anti-inflammatory drug-mediated ulcers, Gastric and Duodenal ulcers, and Helicobacter pylori eradication.

Product Launches and Product Expansions:

Aug-2021: Dr Reddy's Laboratories introduced over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the US market. This tablet is an over-the-counter non-steroidal anti-inflammatory drug (NSAID) for usage as a pain reliever and fever reducer.

May-2022: Dr. Reddy's Laboratories released Ketorolac Tromethamine Tablets USP, 10 mg, a therapeutic generic equivalent of the reference listed drug Toradol Tablets, 10 mg in the U.S. market. This product is a nonsteroidal anti-inflammatory drug (NSAID) demonstrated for the short-term management of moderately serious acute pain, which offers analgesia at the opioid stage and only as continuation treatment after intravenous or intramuscular dosing of ketorolac tromethamine, if necessary.

Approvals and Trails:

Feb-2022: Bayer received approval for Kerendia in the EU for adult people with chronic kidney disease related to type 2 diabetes. Kerendia is non-steroidal, which is a selective mineralocorticoid receptor (MR) antagonist to demonstrate positive kidney and cardiovascular (CV) results.

Jan-2022: Pfizer received approval from the United States (U.S.) Food and Drug Administration (FDA) for CIBINQO, an oral, once-daily, Janus kinase 1 (JAK1) inhibitor. CIBINQO is recommended for doses of 100 mg and 200 mg, along with the 200 mg dose being recommended for people for whom the medicine of 100 mg dose is less effective.

Dec-2020: GlaxoSmithKline got approval for BENLYSTA from the US Food and Drug Administration (FDA). This product is launched for the treatment of adult patients with active lupus nephritis (LN) who are getting standard therapy.

Sep-2020: Pfizer got the approval for XELJANZ from the United States (U.S.) Food and Drug Administration (FDA). This product is for the treatment of children and adolescents 2 years and elder with active polyarticular course juvenile idiopathic arthritis (pcJIA). In addition, the approval would make XELJANZ the first and only Janus kinase (JAK) inhibitor approved in the U.S. for the treatment of pcJIA.

Mar-2020: GlaxoSmithKline received approval from the U.S. Food and Drug Administration (FDA) for Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief. This product would offer relief for various symptoms and is the first formulation, which integrates ibuprofen and acetaminophen, two powerful ingredients related to OTC pain relief that would work in multiple ways.

Feb-2020: GlaxoSmithKline got approval from the U.S. Food and Drug Administration (FDA) for Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever). This product is an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, elbow, wrist, ankle foot, or knee in adults.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration

  • Oral
  • Topical
  • Others

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Disease Indication

  • Arthritis
  • Migraine
  • Ophthalmic Diseases
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Dr. Reddy's Laboratories Ltd.
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Bayer AG
  • Teva Pharmaceuticals Industries Ltd.
  • Eli Lilly And Company
  • Sanofi S.A.
  • AstraZeneca PLC
  • Viatris, Inc.
  • Merck & Co., Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
    • 1.4.2 Global Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
    • 1.4.3 Global Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
    • 1.4.4 Global Non-steroidal Anti-inflammatory Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market

Chapter 4. Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration

  • 4.1 Global Oral Market by Region
  • 4.2 Global Topical Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel

  • 5.1 Global Retail Pharmacy Market by Region
  • 5.2 Global Hospital Pharmacy Market by Region
  • 5.3 Global Online Pharmacy Market by Region

Chapter 6. Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication

  • 6.1 Global Arthritis Market by Region
  • 6.2 Global Migraine Market by Region
  • 6.3 Global Ophthalmic Diseases Market by Region
  • 6.4 Global Others Market by Region

Chapter 7. Global Non-steroidal Anti-inflammatory Drugs Market by Region

  • 7.1 North America Non-steroidal Anti-inflammatory Drugs Market
    • 7.1.1 North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
      • 7.1.1.1 North America Oral Market by Country
      • 7.1.1.2 North America Topical Market by Country
      • 7.1.1.3 North America Others Market by Country
    • 7.1.2 North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
      • 7.1.2.1 North America Retail Pharmacy Market by Country
      • 7.1.2.2 North America Hospital Pharmacy Market by Country
      • 7.1.2.3 North America Online Pharmacy Market by Country
    • 7.1.3 North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.1.3.1 North America Arthritis Market by Country
      • 7.1.3.2 North America Migraine Market by Country
      • 7.1.3.3 North America Ophthalmic Diseases Market by Country
      • 7.1.3.4 North America Others Market by Country
    • 7.1.4 North America Non-steroidal Anti-inflammatory Drugs Market by Country
      • 7.1.4.1 US Non-steroidal Anti-inflammatory Drugs Market
        • 7.1.4.1.1 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.1.4.1.2 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.1.4.1.3 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.1.4.2 Canada Non-steroidal Anti-inflammatory Drugs Market
        • 7.1.4.2.1 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.1.4.2.2 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.1.4.2.3 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.1.4.3 Mexico Non-steroidal Anti-inflammatory Drugs Market
        • 7.1.4.3.1 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.1.4.3.2 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.1.4.3.3 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.1.4.4 Rest of North America Non-steroidal Anti-inflammatory Drugs Market
        • 7.1.4.4.1 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.1.4.4.2 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.1.4.4.3 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  • 7.2 Europe Non-steroidal Anti-inflammatory Drugs Market
    • 7.2.1 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
      • 7.2.1.1 Europe Oral Market by Country
      • 7.2.1.2 Europe Topical Market by Country
      • 7.2.1.3 Europe Others Market by Country
    • 7.2.2 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
      • 7.2.2.1 Europe Retail Pharmacy Market by Country
      • 7.2.2.2 Europe Hospital Pharmacy Market by Country
      • 7.2.2.3 Europe Online Pharmacy Market by Country
    • 7.2.3 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.3.1 Europe Arthritis Market by Country
      • 7.2.3.2 Europe Migraine Market by Country
      • 7.2.3.3 Europe Ophthalmic Diseases Market by Country
      • 7.2.3.4 Europe Others Market by Country
    • 7.2.4 Europe Non-steroidal Anti-inflammatory Drugs Market by Country
      • 7.2.4.1 Germany Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.1.1 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.1.2 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.1.3 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.2 UK Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.2.1 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.2.2 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.2.3 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.3 France Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.3.1 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.3.2 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.3.3 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.4 Russia Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.4.1 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.4.2 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.4.3 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.5 Spain Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.5.1 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.5.2 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.5.3 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.6 Italy Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.6.1 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.6.2 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.6.3 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.2.4.7 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market
        • 7.2.4.7.1 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.2.4.7.2 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.2.4.7.3 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  • 7.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
    • 7.3.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
      • 7.3.1.1 Asia Pacific Oral Market by Country
      • 7.3.1.2 Asia Pacific Topical Market by Country
      • 7.3.1.3 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
      • 7.3.2.1 Asia Pacific Retail Pharmacy Market by Country
      • 7.3.2.2 Asia Pacific Hospital Pharmacy Market by Country
      • 7.3.2.3 Asia Pacific Online Pharmacy Market by Country
    • 7.3.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.3.1 Asia Pacific Arthritis Market by Country
      • 7.3.3.2 Asia Pacific Migraine Market by Country
      • 7.3.3.3 Asia Pacific Ophthalmic Diseases Market by Country
      • 7.3.3.4 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country
      • 7.3.4.1 China Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.1.1 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.1.2 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.1.3 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.2 Japan Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.2.1 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.2.2 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.2.3 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.3 India Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.3.1 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.3.2 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.3.3 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.4 South Korea Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.4.1 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.4.2 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.4.3 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.5 Singapore Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.5.1 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.5.2 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.5.3 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.6 Malaysia Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.6.1 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.6.2 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.6.3 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.3.4.7 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
        • 7.3.4.7.1 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.3.4.7.2 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.3.4.7.3 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  • 7.4 LAMEA Non-steroidal Anti-inflammatory Drugs Market
    • 7.4.1 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
      • 7.4.1.1 LAMEA Oral Market by Country
      • 7.4.1.2 LAMEA Topical Market by Country
      • 7.4.1.3 LAMEA Others Market by Country
    • 7.4.2 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
      • 7.4.2.1 LAMEA Retail Pharmacy Market by Country
      • 7.4.2.2 LAMEA Hospital Pharmacy Market by Country
      • 7.4.2.3 LAMEA Online Pharmacy Market by Country
    • 7.4.3 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.3.1 LAMEA Arthritis Market by Country
      • 7.4.3.2 LAMEA Migraine Market by Country
      • 7.4.3.3 LAMEA Ophthalmic Diseases Market by Country
      • 7.4.3.4 LAMEA Others Market by Country
    • 7.4.4 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country
      • 7.4.4.1 Brazil Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.1.1 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.1.2 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.1.3 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.2 Argentina Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.2.1 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.2.2 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.2.3 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.3 UAE Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.3.1 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.3.2 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.3.3 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.4 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.4.1 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.4.2 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.4.3 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.5 South Africa Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.5.1 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.5.2 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.5.3 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.6 Nigeria Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.6.1 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.6.2 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.6.3 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
      • 7.4.4.7 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market
        • 7.4.4.7.1 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
        • 7.4.4.7.2 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
        • 7.4.4.7.3 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication

Chapter 8. Company Profiles

  • 8.1 Dr. Reddy's Laboratories Ltd.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Product Launches and Product Expansions:
  • 8.2 Pfizer, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional & Segmental Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Approvals and Trails:
  • 8.3 GlaxoSmithKline PLC
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Approvals and Trails:
  • 8.4 Bayer AG
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Approvals and Trails:
  • 8.5 Teva Pharmaceutical Industries Ltd.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Product Launches and Product Expansions:
  • 8.6 Eli Lilly And Company
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Approvals and Trails:
  • 8.7 Sanofi S.A.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
  • 8.8 AstraZeneca PLC
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expenses
  • 8.9 Viatris, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.10. Merck & Co., Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expenses